Boehringer Ingelheim Investigational Site

Orlando, Florida

Use our guide to learn which trials are right for you!

We've found
14 trials
at this facility
Diabetes Mellitus, Type 2 Clinical Trial
Linaglitpin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes
Status: Enrolling
Updated: 10/17/2012
mi
from
Orlando, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
Status: Enrolling, Phase IV
Updated: 4/4/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
GLORIA-AF Registry Program - Second and Third Phases
Status: Enrolling
Updated: 4/4/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling, Phase III
Updated: 4/4/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Glioma Clinical Trial
BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
Status: Enrolling, Phase II
Updated: 3/21/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.
Status: Enrolling, Phase III
Updated: 3/14/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 1/12/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling, Phase III
Updated: 1/18/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Status: Enrolling, Phase III
Updated: 1/12/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Oncology Clinical Trial
LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
Status: Enrolling, Phase III
Updated: 1/6/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 3/4/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2
Status: Enrolling, Phase III
Updated: 1/14/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).
Status: Enrolling, Phase III
Updated: 2/11/2016
mi
from
Orlando, FL
Click here to add this to my saved trials